Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation

Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation

US Patent 6630498 · Granted Oct 7, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fulvestrant formulations2019
Fulvestrant formulations2017
Fulvestrant formulations2015
Docetaxel formulations with lipoic acid2014
Stable amifostine liquid concentrate2014
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid2013
Lyophilization process and products obtained thereby2012
Alcohol free formulation of argatroban2010
Alcohol free formulation of argatroban2009
Inhalation administration of biophosphonates2004
High drug load immediate and modified release oral dosage formulations and proce2003
Bioenhanced formulations comprising eprosartan in oral solid dosage form2003